ArticleJournal of medical cases2026

Challenges of Hepatitis B Virus Reactivation and CD19 Testing Following Tafasitamab Plus Lenalidomide for Relapsed Diffuse Large B-Cell Lymphoma.

Ta-Chuan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.